ESC Premium Access

Bedside PCI risk score.

Congress Presentation

About the speaker

Doctor Luokai Wang

National Heart Centre Singapore, Singapore (Singapore)
0 follower

14 more presentations in this session

5-year results of the complete versus culprit vessel percutaneous coronary intervention in multivessel disease using drug-eluting stents II study. A prospective, randomized controlled trial.

Speaker: Mr N. Fagel (Amsterdam, NL)


Predictors of multiple percutaneous coronary interventions in a statewide database of 114,588 patients

Speaker: Professor J. Kostis (New Brunswick, US)


Landmark analysis of clinical outcome following first-generation vs newer-generation coronary drug-eluting stent implantation: A pooled analysis of SORT OUT III-V studies

Speaker: Professor M. Maeng (Aarhus, DK)


Percutaneous coronary intervention with drug-eluting stent versus coronary artery bypass grafting: a meta-analysis of patients with left main coronary artery disease

Speaker: Doctor N. Spinthakis (Exeter, GB)


Post-procedural increase of urinary kidney injury molecule type 1 predicts outcome in patients with coronary artery disease submitted to coronary angiography

Speaker: Associate Professor M. Wybraniec (Katowice, PL)


Access the full session

Poster session 2 - Long-Term outcomes of PCI

Speakers: Doctor L. Wang, Mr N. Fagel, Professor J. Kostis, Professor M. Maeng, Doctor N. Spinthakis...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb